Candidiasis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 130 pages | ID: C62A184DBBE6EN
VPAResearch

Abstracts

Candidiasis Drug pipeline report- 2020 is an annual R&D review of Candidiasis pipeline candidates. The report presents the current status of all major Candidiasis therapeutic compounds. Detailed insights into Candidiasis pipeline development, current status, companies, drug profiles and Candidiasis preclinical and clinical trials are included.

2020 Candidiasis Pipeline Market Insights
Candidiasis disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Candidiasis therapies, pipeline by phase and others are included.

Candidiasis pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Candidiasis Therapeutic Drug candidates
Both active and inactive Candidiasis pipeline drug candidates are included in the report

Candidiasis Clinical Trials and preclinical Studies
Candidiasis In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Candidiasis pipeline market developments
Candidiasis Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Candidiasis pipeline companies in active development
The report analyzes Candidiasis pipeline of the below companies-

Acea Biotech Inc, Amplyx Pharmaceuticals Inc, APEIRON Biologics AG, Bakker Medical Srl, Beta Pharma Inc, Biosergen AS, Cellix Bio Pvt Ltd, Cidara Therapeutics Inc, CSA Biotechnologies LLC, Fox Chase Chemical Diversity Center Inc, Gedea Biotech AB, General Biologicals Corp, Grupo Ferrer Internacional SA, Helix BioMedix Inc, Hennepin Life Sciences LLC, iCo Therapeutics Inc., Jiangsu Hengrui Medicine Co Ltd, LipoSeuticals Inc, Matinas BioPharma, Mycovia Pharmaceuticals, Nanomerics Ltd, Nosopharm SAS, Novabiotics Ltd, NovaDigm Therapeutics Inc, Novartis AG, Onxeo SA, Oryn Therapeutics, Profem GmbH, Pulmocide Ltd, Sano Chemicals Inc, Scynexis Inc, Sealife PHARMA GMBH, Shaanxi Synthetic Pharmaceutical Co Ltd, TGV Therapeutics, Toltec Pharmaceuticals LLC, Viamet Pharmaceuticals Inc, Visterra Inc, Wellstat Vaccines LLC

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
38 Companies investing in Candidiasis pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Candidiasis pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included

Contents

1. CANDIDIASIS PIPELINE MARKET INSIGHTS, 2020

1.1 Candidiasis Disease Overview
1.2 Candidiasis Drug Pipeline Snapshot, 2020
  1.2.1 Candidiasis Pipeline Drugs by Phase
  1.2.2 Candidiasis Pipeline Drugs by Company
  1.2.3 Candidiasis Pipeline Drugs by Mechanism of Action
  1.2.4 Candidiasis Pipeline Drugs by Route of Administration

2. CANDIDIASIS COMPANY WISE PIPELINE DETAILS

Acea Biotech Inc Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Amplyx Pharmaceuticals Inc Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
APEIRON Biologics AG Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Bakker Medical Srl Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Beta Pharma Inc Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Biosergen AS Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Cellix Bio Pvt Ltd Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Cidara Therapeutics Inc Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
CSA Biotechnologies LLC Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Fox Chase Chemical Diversity Center Inc Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Gedea Biotech AB Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
General Biologicals Corp Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Grupo Ferrer Internacional SA Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Helix BioMedix Inc Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Hennepin Life Sciences LLC Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
iCo Therapeutics Inc. Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Jiangsu Hengrui Medicine Co Ltd Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
LipoSeuticals Inc Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Matinas BioPharma Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Mycovia Pharmaceuticals Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Nanomerics Ltd Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Nosopharm SAS Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Novabiotics Ltd Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
NovaDigm Therapeutics Inc Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Novartis AG Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Onxeo SA Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Oryn Therapeutics Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Profem GmbH Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Pulmocide Ltd Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Sano Chemicals Inc Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Scynexis Inc Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Sealife PHARMA GMBH Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Shaanxi Synthetic Pharmaceutical Co Ltd Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
TGV Therapeutics Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Toltec Pharmaceuticals LLC Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Viamet Pharmaceuticals Inc Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Visterra Inc Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Wellstat Vaccines LLC Candidiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. CANDIDIASIS DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. CANDIDIASIS PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts